MedPath

To Evaluate Ezetimibe Plus Atorvastatin Versus Atorvastatin in Patients With High Cholesterol Not Controlled on Atorvastatin 40 mg (0653-090)

Phase 3
Completed
Conditions
Hypercholesterolemia
Interventions
Registration Number
NCT00276484
Lead Sponsor
Organon and Co
Brief Summary

To Evaluate and Compare the Efficacy and Safety of Ezetimibe Plus Atorvastatin Versus Atorvastatin in Hypercholesterolemic Patients at High Risk for Coronary Heart Disease Not Adequately Controlled on Atorvastatin 40 mg.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
579
Inclusion Criteria
  • Patient with LDL-C >70 mg/dL & on a stable dose of atorvastatin 40 mg
Exclusion Criteria
  • Pregnant or lactating women or intending to become pregnant
  • Patient with sensitivity or intolerance to ezetimibe or atorvastatin

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
2ezetimibeAtorvastatin 40 mg + ezetimibe 10 mg
1atorvastatinAtorvastatin 80 mg
2atorvastatinAtorvastatin 40 mg + ezetimibe 10 mg
Primary Outcome Measures
NameTimeMethod
Percent Change From Baseline to Week 6 in Low-Density Lipoprotein (LDL)-CBaseline and 6 weeks

Percent Change in LDL-C = \[(week 6 value - baseline value)/baseline value\]\*100%

Secondary Outcome Measures
NameTimeMethod
Percent Change From Baseline to Week 6 in Triglycerides (TG)Baseline and 6 Weeks

Percent Change in TG = \[(week 6 value - baseline value)/baseline value\]\*100%

Number of Patients Who Attained Target Low-Density Lipoprotein Cholesterol (LDL-C) <70 mg/dL at Week 66 Weeks
Percent Change From Baseline to Week 6 in High-Density Lipoprotein Cholesterol (HDL-C)Baseline and 6 weeks

Percent Change in HDL-C = \[(week 6 value - baseline value)/baseline value\]\*100%

Percent Change From Baseline to Week 6 in Non-High-Density Lipoprotein Cholesterol (Non-HDL-C)Baseline and 6 Weeks

Percent Change in Non-HDL-C = \[(week 6 value - baseline value)/baseline value\]\*100%

Percent Change From Baseline to Week 6 in Total-CholesterolBaseline and 6 Weeks

Percent Change in Total-C = \[(week 6 value - baseline value)/baseline value\]\*100%

Percent Change From Baseline to Week 6 in Apolipoprotein B (Apo B)Baseline and 6 Weeks

Percent Change in Apo B = \[(week 6 value - baseline value)/baseline value\]\*100%

Percent Change From Baseline to Week 6 in Low-Density Lipoprotein-Cholesterol:High-Density Lipoprotein-Cholesterol (LDL-C:HDL-C) RatioBaseline and 6 Weeks

Percent Change in LDL-C:HDL-C Ratio = \[(week 6 ratio - baseline ratio)/baseline ratio\]\*100%

Percent Change From Baseline to Week 6 in Apolipoprotein A-I (Apo A-I)Baseline and 6 Weeks

Percent Change in Apo A-I = \[(week 6 value - baseline value)/baseline value\]\*100%

Percent Change From Baseline to Week 6 in Apolipoprotein B:Apolipoprotein A-I (Apo B:Apo A-I) RatioBaseline and 6 Weeks

Percent Change in Apo B:Apo A-I Ratio = \[(week 6 ratio - baseline ratio)/baseline ratio\]\*100%

Percent Change From Baseline to Week 6 in Total-Cholesterol (TC):High-Density Lipoprotein Cholesterol (HDL-C) RatioBaseline and 6 Weeks

Percent Change in TC:HDL-C Ratio = \[(week 6 ratio - baseline ratio)/baseline ratio\]\*100%

Percent Change From Baseline to Week 6 in Non-High-Density Lipoprotein-Cholesterol:High-Density Lipoprotein-Cholesterol (Non-HDL-C:HDL-C) RatioBaseline and 6 Weeks

Percent Change in non-HDL-C:HDL-C Ratio = \[(week 6 ratio - baseline ratio)/baseline ratio\]\*100%

Percent Change From Baseline to Week 6 in C Reactive Protein (CRP)Baseline and 6 Weeks

Percent Change in CRP = \[(week 6 value - baseline value)/baseline value\]\*100%

© Copyright 2025. All Rights Reserved by MedPath